Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
AD     Remove this Ad

SUVEN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -7.26-24.63-7.9547.4313.49

What is the latest Core EBITDA Growth ratio of SUVEN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SUVEN PHARMACEUTICALS is -7.26 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-7.26
Mar2024-24.63
Mar2023-7.95
Mar202247.43
Mar202113.49

How is Core EBITDA Growth of SUVEN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -7.26
Negative
Mar2024 -24.63
Negative
Mar2023 -7.95
Negative
Mar2022 47.43
251.59
Mar2021 13.49 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹12,038.5 Cr -0.3% -18.1% -70.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,054.0 Cr 0.9% 6.2% -1.3% Stock Analytics
DIVIS LABORATORIES ₹167,075.0 Cr 2% 4.8% 4.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,904.0 Cr 3.6% 6% 36.9% Stock Analytics
CIPLA ₹107,358.0 Cr -0.1% -3% -8.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,813.0 Cr 1% 10.8% 4.7% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-0.3%

-18.1%

-70.9%

SENSEX

-1.4%

0.4%

8.3%


You may also like the below Video Courses